(EXXT) iShares NASDAQ-100 (DE) - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: DE000A0F5UF5

Large-Cap, Growth, US, Equities

Description: EXXT iShares NASDAQ-100 (DE)

The iShares NASDAQ-100 UCITS ETF (DE) EUR, traded on XETRA under the ticker symbol EXXT, is a US Large-Cap Growth Equity ETF originating from Germany. It tracks the Morningstar US LM Brd Growth NR USD Index, providing investors with exposure to a broad range of large-cap growth stocks in the US market.

From a technical standpoint, the ETF has demonstrated a bullish trend, with its current price of 185.68 EUR sitting above its 20-day Simple Moving Average (SMA) of 183.78 EUR and 50-day SMA of 172.81 EUR. Although its slightly below its 200-day SMA of 183.82 EUR, the overall upward momentum is maintained. The Average True Range (ATR) stands at 3.19 EUR, or 1.72%, indicating moderate volatility. Given its 52-week high of 206.67 EUR and low of 151.66 EUR, the ETF has shown resilience and potential for growth.

Fundamentally, the ETF boasts an Assets Under Management (AUM) of 4153.84 million EUR, underscoring its significant presence in the market and investor confidence. The tracking of the Morningstar US LM Brd Growth NR USD Index means it is exposed to a diversified portfolio of US large-cap growth stocks, which are typically characterized by their potential for above-average growth.

Forecasting based on the provided technical and fundamental data, its plausible that EXXT will continue its upward trajectory, driven by the overall growth trend in US large-cap stocks. The ETFs position above its 20-day and 50-day SMAs is a bullish indicator. However, the slight dip below its 200-day SMA warrants cautious observation. If the AUM continues to grow and the tracked index performs well, EXXT is likely to see its price appreciate further. A potential target could be a retest of its 52-week high, around 206.67 EUR, assuming the current market conditions and growth trends persist. Conversely, a drop below the 50-day SMA could signal a correction, potentially targeting the 52-week low. Investors should closely monitor the ATR for increasing volatility, which could signal a significant move in either direction.

Additional Sources for EXXT ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EXXT ETF Overview

Market Cap in USD 4,871m
Category US Large-Cap Growth Equity
IPO / Inception 2006-03-27

EXXT ETF Ratings

Growth Rating 66.8
Fundamental -
Dividend Rating 48.2
Rel. Strength -8.8
Analysts -
Fair Price Momentum 175.87 EUR
Fair Price DCF -

EXXT Dividends

Dividend Yield 12m 0.25%
Yield on Cost 5y 0.53%
Annual Growth 5y 9.56%
Payout Consistency 84.4%
Payout Ratio %

EXXT Growth Ratios

Growth Correlation 3m 82.5%
Growth Correlation 12m 23.6%
Growth Correlation 5y 86.4%
CAGR 5y 15.82%
CAGR/Max DD 5y 0.50
Sharpe Ratio 12m 0.33
Alpha -12.21
Beta 1.019
Volatility 14.65%
Current Volume 55.5k
Average Volume 20d 28.7k
What is the price of EXXT shares?
As of July 02, 2025, the stock is trading at EUR 185.56 with a total of 55,537 shares traded.
Over the past week, the price has changed by +0.17%, over one month by +2.25%, over three months by +6.48% and over the past year by +4.10%.
Is iShares NASDAQ-100 (DE) a good stock to buy?
Yes. Based on ValueRay's Analyses, iShares NASDAQ-100 (DE) (XETRA:EXXT) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 66.78 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXXT is around 175.87 EUR . This means that EXXT is currently overvalued and has a potential downside of -5.22%.
Is EXXT a buy, sell or hold?
iShares NASDAQ-100 (DE) has no consensus analysts rating.
What are the forecasts for EXXT share price target?
According to our own proprietary Forecast Model, EXXT iShares NASDAQ-100 (DE) will be worth about 207 in July 2026. The stock is currently trading at 185.56. This means that the stock has a potential upside of +11.53%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 207 11.5%